Barbiturates are a class of sedative drugs that slow down the central nervous system. First synthesized in 1864 and introduced as a sleep aid in 1904, they were once among the most widely prescribed medications in the world. Today their use has narrowed dramatically because of a dangerously thin line between an effective dose and a lethal one. Phenobarbital, for example, has a therapeutic blood level of 10 to 30 mg/L, while 80 mg/L can be fatal.
How Barbiturates Work in the Brain
Your brain has a natural braking system that keeps nerve cells from firing too fast. A chemical messenger called GABA activates this system by opening tiny channels in nerve cells that let chloride ions flow in, which quiets those cells down. Barbiturates latch onto the same receptor that GABA uses and force those chloride channels to stay open longer than they normally would. Research published in The Journal of Physiology showed that barbiturates shift the channels toward their longest open state, dramatically increasing the calming effect.
At low doses, this produces relaxation and drowsiness. At higher doses, the same mechanism suppresses brain areas that control breathing, blood pressure, and heart rate. That is what makes barbiturates so dangerous: the drug doesn’t switch to a different effect at high doses, it simply amplifies the same one until critical body functions shut down.
Types of Barbiturates
Barbiturates are grouped by how quickly they take effect and how long they last:
- Ultra-short acting: Thiopental and methohexital. These take effect within seconds when injected and wear off in minutes. They were historically used to induce anesthesia before surgery.
- Short and intermediate acting: Pentobarbital, secobarbital, amobarbital, and butalbital. These last a few hours and were once common sleeping pills. Butalbital is still found in some headache medications.
- Long acting: Phenobarbital. This can remain active in the body for a day or more and is the barbiturate most commonly prescribed today, primarily for seizure disorders.
What Barbiturates Are Still Used For
For most of the 20th century, barbiturates were the go-to treatment for anxiety, insomnia, and seizures. That changed in the 1960s and 1970s as safer alternatives, particularly benzodiazepines, became available. Today only a few barbiturates remain in regular clinical use.
Phenobarbital is still prescribed for certain types of epilepsy, especially in parts of the world where newer seizure medications are unavailable or too expensive. Butalbital shows up in combination headache medications paired with caffeine and pain relievers. Thiopental and methohexital see limited use in anesthesia, though they have largely been replaced by newer agents. Pentobarbital is occasionally used in hospitals to control dangerously elevated brain pressure or severe, prolonged seizures that don’t respond to other drugs.
Side Effects and Safety Risks
Even at prescribed doses, barbiturates can cause drowsiness, poor coordination, slowed thinking, and dizziness. They lower blood pressure and can slow breathing. Allergic skin reactions and mild liver injury are possible, and phenobarbital in particular has been linked to serious skin conditions and liver damage in rare cases. In pregnant women, phenobarbital is associated with birth defects.
The core safety problem is the narrow therapeutic index. The dose that produces a medical benefit is not far from the dose that causes serious harm. Combining barbiturates with alcohol, opioids, or benzodiazepines multiplies the risk of dangerously slowed breathing and oversedation. The 2023 Beers Criteria from the American Geriatrics Society specifically discourages barbiturate use in older adults because of the high rate of physical dependence, rapid tolerance to sleep benefits, and the risk of overdose even at low doses.
Dependence and Withdrawal
Barbiturates are highly addictive. Physical dependence can develop within weeks of regular use, and the body builds tolerance quickly, meaning you need progressively larger doses to get the same effect. This tolerance-dependence cycle is a major reason barbiturates fell out of favor.
Withdrawal from barbiturates is medically serious and can be life-threatening. Symptoms include anxiety, tremors, insomnia, nausea, and in severe cases, seizures. Research tracking patients withdrawing from phenobarbital found that seizure risk climbed sharply once blood levels dropped below 20 mg/L. Unlike opioid withdrawal, which is intensely uncomfortable but rarely fatal, barbiturate withdrawal can kill through seizures or cardiovascular collapse. Stopping these drugs requires a gradual, supervised taper over weeks.
What Happens in an Overdose
There is no antidote for barbiturate poisoning. Unlike opioid overdoses, which can be reversed with naloxone, or benzodiazepine overdoses, which respond to flumazenil, a barbiturate overdose has no specific reversal agent. Treatment is entirely supportive: maintaining breathing with a ventilator, stabilizing blood pressure, and preventing hypothermia, since barbiturates can suppress the brain’s temperature regulation.
Overdose symptoms range from extreme drowsiness and slurred speech to coma, stopped breathing, and dangerously low blood pressure. The heart may slow or beat irregularly, and body temperature can drop. With appropriate hospital care, in-hospital mortality from barbiturate toxicity runs between 0.5% and 2%, but outcomes are much worse without medical intervention or when other depressant drugs are involved.
How Barbiturates Affect Other Medications
Barbiturates rev up your liver’s drug-processing enzymes. This means the liver breaks down other medications faster than normal, potentially making them less effective. This is a significant problem for people taking blood thinners, hormonal birth control, certain heart medications, or other drugs that pass through the liver. Even after stopping a barbiturate, it can take weeks for liver enzyme activity to return to baseline. This interaction is one more reason prescribers generally prefer alternatives.
Legal Status
All barbiturates are controlled substances in the United States. Their scheduling varies by how likely they are to be abused. Amobarbital and pentobarbital are Schedule II, the same category as morphine and fentanyl, reflecting high abuse potential. Most others, including phenobarbital, secobarbital, and methohexital, fall under Schedule IV. Butalbital, thiopental, and barbiturates not individually listed are Schedule III. Every barbiturate prescription must follow DEA requirements for controlled substances.